[Persistence to treatment and resources use with inhaled fixed-dose combinations of corticosteroids and long-acting β-adrenergic agonists for the treatment of asthma: A population-based retrospective study]

Autor: A, Sicras-Mainar, S, Traseira-Lugilde, T, Fernández-Sánchez, R, Navarro-Artieda

Publikováno v: Semergen. 44(7)

To determine the persistence, exacerbations, and use of resources in patients who use inhaler treatment with fluticasone propionate/formoterol (PF/Form) in relation with other combinations of inhaled corticosteroid/long-acting β-adrenergic (ICS/LABA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d2d646ededb2ca0243de3430cd405b43
https://pubmed.ncbi.nlm.nih.gov/29545018

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Low-Dose Methoxyflurane versus Standard of Care Analgesics for Emergency Trauma Pain: A Systematic Review and Meta-Analysis of Pooled Data.

Autor: Fabbri A; Department of Emergency Medicine, Morgagni-Pierantoni Hospital, Forli, Italy., Borobia AM; Clinical Pharmacology Department, La Paz University Hospital, School of Medicine, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain., Ricard-Hibon A; Emergency Department SAMU-SMUR 95, CHG Pontoise-Beaumont/Oise, Pontoise, France., Coffey F; DREEAM: Department of Research and Education in Emergency Medicine, Acute Medicine and Major Trauma, Nottingham University Hospitals NHS Trust, Nottingham, UK., Caumont-Prim A; eXYSTAT, Malakoff, France., Montestruc F; eXYSTAT, Malakoff, France., Soldi A; Mundipharma Pharmaceuticals Srl, Milan, Italy., Traseira Lugilde S; Mundipharma Pharmaceuticals S.L., Madrid, Spain., Dickerson S; Mundibiopharma Limited, Cambridge, UK.

Publikováno v: Journal of pain research [J Pain Res] 2021 Jan 20; Vol. 14, pp. 93-105. Date of Electronic Publication: 2021 Jan 20 (Print Publication: 2021).